Difference between revisions of "Interferon alfa-2b (Intron-A)"
m (Text replace - "package insert<ref name="insert"></ref>." to "prescribing information.<ref name="insert"></ref>") |
(updated content) |
||
| Line 1: | Line 1: | ||
| + | Also known as (caution, may also contain names for interferon beta, interferon gamma, or interferon alfa-2a): Advaferon, Alfaferone, Berofor, Biogamma, Canferon A, Cytoferon, Egiferon, Feron, Fiblaferon, Frone, Finnferon-Alpha, Heberon Alfa R, Humoferon, IFN Alpha, Imufor, Imukin, INF, Inferax, Infergen, Inmutag, Interfero, Interferon Alfanative, Interferon Human, Interferon Leucocyticum, Interferon Lymphoblastoid, Interferonum Leucocyticum, Laroferon, Multiferon, Namalvin, OIF, Polyferon, Realdiron, Roceron-A, Sumiferon, or Wellferon. | ||
| + | |||
==General information== | ==General information== | ||
| − | Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways. Mechanism not fully understood.<ref name="insert">[http://www.spfiles.com/piintrona.pdf Interferon alfa-2b (Intron-A) package insert]</ref><ref>[ | + | Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways. Mechanism not fully understood.<ref name="insert">[http://www.spfiles.com/piintrona.pdf Interferon alfa-2b (Intron-A) package insert]</ref><ref>[[Media:Interferonalfa-2b.pdf | Interferon alfa-2b (Intron-A) package insert (locally hosted backup)]]</ref><ref>[http://www.introna.com Intron-A manufacturer's website]</ref> |
<br>Route: SC, IM, IV, intralesional | <br>Route: SC, IM, IV, intralesional | ||
<br>Extravasation: no information | <br>Extravasation: no information | ||
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref> | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref> | ||
| + | |||
| + | ==Diseases for which it is used== | ||
| + | *[[Melanoma]] | ||
| + | *[[Multiple myeloma]] | ||
| + | *[[Transplant conditioning regimens]] | ||
==Patient drug information== | ==Patient drug information== | ||
| − | *[http://chemocare.com/ | + | *[http://chemocare.com/chemotherapy/drug-info/intron-a-interferon-alfa-2b.aspx Interferon alfa-2b (Intron-A) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/intron-a-interferon-alfa-2b.aspx Interferon alfa-2b (Intron-A) patient drug information (Chemocare)]</ref> |
*[http://www.uptodate.com/contents/interferon-alfa-2b-patient-drug-information Interferon alfa-2b (Intron-A) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/interferon-alfa-2b-patient-drug-information Interferon alfa-2b (Intron-A) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/interferon-alfa-2b-patient-drug-information Interferon alfa-2b (Intron-A) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/interferon-alfa-2b-patient-drug-information Interferon alfa-2b (Intron-A) patient drug information (UpToDate)]</ref> | ||
==References== | ==References== | ||
<references/> | <references/> | ||
| + | |||
| + | [[Category:Drug index]] | ||
| + | [[Category:Immunotherapy]] | ||
| + | [[Category:Melanoma medications]] | ||
| + | [[Category:Multiple myeloma medications]] | ||
| + | [[Category:Transplant medications]] | ||
Revision as of 00:07, 17 March 2013
Also known as (caution, may also contain names for interferon beta, interferon gamma, or interferon alfa-2a): Advaferon, Alfaferone, Berofor, Biogamma, Canferon A, Cytoferon, Egiferon, Feron, Fiblaferon, Frone, Finnferon-Alpha, Heberon Alfa R, Humoferon, IFN Alpha, Imufor, Imukin, INF, Inferax, Infergen, Inmutag, Interfero, Interferon Alfanative, Interferon Human, Interferon Leucocyticum, Interferon Lymphoblastoid, Interferonum Leucocyticum, Laroferon, Multiferon, Namalvin, OIF, Polyferon, Realdiron, Roceron-A, Sumiferon, or Wellferon.
General information
Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways. Mechanism not fully understood.[1][2][3]
Route: SC, IM, IV, intralesional
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
Patient drug information
- Interferon alfa-2b (Intron-A) patient drug information (Chemocare)[4]
- Interferon alfa-2b (Intron-A) patient drug information (UpToDate)[5]